▮ DFV TERMINAL
--:--:-- UTC SIGN IN
F1 Terminal / BIB

BIB — ProShares Ultra Nasdaq Biotechnology

—
NGM · Health Care · Trading · CIK ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
No quarterly fundamentals indexed for this ticker.

Max Pain — expiry 2026-08-21 (volume-derived — Yahoo OI feed degraded)

max pain strike: $74.00 · spot: $84.95 · call volume: 15 · put volume: 12
Expected Move to 2026-08-21: ±$22.45 (26.43%) — implied range $62.50 – $107.40 · ATM straddle on $85.00 strike

News headlines (Yahoo Finance, 1h cache)

Biopharma Stocks Rally After Trump Threatens 100% Pharmaceuticals Tariff
2025-09-26 20:22 · Yahoo
Will Trump's Looming Tariffs Affect Pharma Profits In The Second Half Of 2025?
2025-07-16 20:05 · Yahoo
Trump Threatens Up To 200% Tariffs On Drug Imports. The Market Doesn't Believe Him.
2025-07-08 20:27 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.
SEC EDGAR filings → · StockAnalysis.com → · OpenInsider →